TELA Bio (TELA) Cash from Operations (2018 - 2026)

TELA Bio's Cash from Operations history runs 9 years deep, the most recent figure standing at 11170000.0 for Q1 2026.

• In Q1 2026, Cash from Operations fell 14.86% year-over-year to 11170000.0; the TTM figure through Mar 2026 stood at 29664000.0 (up 19.69% YoY), while the FY2025 annual figure was 28219000.0, up 32.16% from the prior year.
• Cash from Operations for Q1 2026 stood at 11170000.0, down from 4870000.0 in the prior quarter.
• The five-year high for Cash from Operations was 4870000.0 in Q4 2025, with the low at 14384000.0 in Q1 2024.
• The 5-year median for Cash from Operations is 10430000.0 (2022), against an average of 9564058.82.
• The sharpest annual moves came in 2022 and 2025: Cash from Operations plunged 107.6% in 2022, then jumped 36.34% in 2025.
• TELA Bio's Cash from Operations stood at 10983000.0 in 2022, then retreated by 0.62% to 11051000.0 in 2023, then soared by 31.85% to 7531000.0 in 2024, then jumped by 35.33% to 4870000.0 in 2025, then slumped by 129.36% to 11170000.0 in 2026.
• Business Quant data shows TELA's Cash from Operations at 11170000.0 in Q1 2026, 4870000.0 in Q4 2025, and 5719000.0 in Q3 2025.